Timothy Springer is a Harvard Medical School immunologist and professor in Boston who invests as an angel investor in early-stage life sciences companies. His profile is most relevant to biotechnology, pharmaceuticals and life sciences founders seeking capital from a scientist angel with deep immunology expertise.